283 related articles for article (PubMed ID: 26696140)
1. Investigation of Fluorescein Derivatives as Substrates of Organic Anion Transporting Polypeptide (OATP) 1B1 To Develop Sensitive Fluorescence-Based OATP1B1 Inhibition Assays.
Izumi S; Nozaki Y; Komori T; Takenaka O; Maeda K; Kusuhara H; Sugiyama Y
Mol Pharm; 2016 Feb; 13(2):438-48. PubMed ID: 26696140
[TBL] [Abstract][Full Text] [Related]
2. Substrate-dependent inhibition of organic anion transporting polypeptide 1B1: comparative analysis with prototypical probe substrates estradiol-17β-glucuronide, estrone-3-sulfate, and sulfobromophthalein.
Izumi S; Nozaki Y; Komori T; Maeda K; Takenaka O; Kusano K; Yoshimura T; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2013 Oct; 41(10):1859-66. PubMed ID: 23920221
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the impact of substrate selection on in vitro organic anion transporting polypeptide 1B1 inhibition profiles for the prediction of drug-drug interactions.
Izumi S; Nozaki Y; Maeda K; Komori T; Takenaka O; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2015 Feb; 43(2):235-47. PubMed ID: 25414411
[TBL] [Abstract][Full Text] [Related]
4. Treatment with proteasome inhibitor bortezomib decreases organic anion transporting polypeptide (OATP) 1B3-mediated transport in a substrate-dependent manner.
Alam K; Farasyn T; Crowe A; Ding K; Yue W
PLoS One; 2017; 12(11):e0186924. PubMed ID: 29107984
[TBL] [Abstract][Full Text] [Related]
5. Contribution of OATP (organic anion-transporting polypeptide) family transporters to the hepatic uptake of fexofenadine in humans.
Shimizu M; Fuse K; Okudaira K; Nishigaki R; Maeda K; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2005 Oct; 33(10):1477-81. PubMed ID: 16014768
[TBL] [Abstract][Full Text] [Related]
6. Influence of non-steroidal anti-inflammatory drugs on organic anion transporting polypeptide (OATP) 1B1- and OATP1B3-mediated drug transport.
Kindla J; Müller F; Mieth M; Fromm MF; König J
Drug Metab Dispos; 2011 Jun; 39(6):1047-53. PubMed ID: 21389119
[TBL] [Abstract][Full Text] [Related]
7. Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3.
Noé J; Portmann R; Brun ME; Funk C
Drug Metab Dispos; 2007 Aug; 35(8):1308-14. PubMed ID: 17470528
[TBL] [Abstract][Full Text] [Related]
8. Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3.
Gozalpour E; Greupink R; Wortelboer HM; Bilos A; Schreurs M; Russel FG; Koenderink JB
Mol Pharm; 2014 Jun; 11(6):1844-55. PubMed ID: 24754247
[TBL] [Abstract][Full Text] [Related]
9. Sodium fluorescein is a probe substrate for hepatic drug transport mediated by OATP1B1 and OATP1B3.
De Bruyn T; Fattah S; Stieger B; Augustijns P; Annaert P
J Pharm Sci; 2011 Nov; 100(11):5018-30. PubMed ID: 21837650
[TBL] [Abstract][Full Text] [Related]
10. Substrate-dependent effects of molecular-targeted anticancer agents on activity of organic anion transporting polypeptide 1B1.
Koide H; Tsujimoto M; Takeuchi A; Tanaka M; Ikegami Y; Tagami M; Abe S; Hashimoto M; Minegaki T; Nishiguchi K
Xenobiotica; 2018 Oct; 48(10):1059-1071. PubMed ID: 29034773
[TBL] [Abstract][Full Text] [Related]
11. The eighth and ninth transmembrane domains in organic anion transporting polypeptide 1B1 affect the transport kinetics of estrone-3-sulfate and estradiol-17beta-D-glucuronide.
Miyagawa M; Maeda K; Aoyama A; Sugiyama Y
J Pharmacol Exp Ther; 2009 May; 329(2):551-7. PubMed ID: 19244099
[TBL] [Abstract][Full Text] [Related]
12. Interaction of Sulfonylureas with Liver Uptake Transporters OATP1B1 and OATP1B3.
Chen Y; Chen L; Zhang H; Huang S; Xiong Y; Xia C
Basic Clin Pharmacol Toxicol; 2018 Aug; 123(2):147-154. PubMed ID: 29498478
[TBL] [Abstract][Full Text] [Related]
13. Contribution of organic anion transporting polypeptide (OATP) 1B1 and OATP1B3 to hepatic uptake of nateglinide, and the prediction of drug-drug interactions via these transporters.
Takanohashi T; Kubo S; Arisaka H; Shinkai K; Ubukata K
J Pharm Pharmacol; 2012 Feb; 64(2):199-206. PubMed ID: 22221095
[TBL] [Abstract][Full Text] [Related]
14. Characterization of 22 Antituberculosis Drugs for Inhibitory Interaction Potential on Organic Anionic Transporter Polypeptide (OATP)-Mediated Uptake.
Parvez MM; Jung JA; Shin HJ; Kim DH; Shin JG
Antimicrob Agents Chemother; 2016 May; 60(5):3096-105. PubMed ID: 26976869
[TBL] [Abstract][Full Text] [Related]
15. Prediction of organic anion-transporting polypeptide 1B1- and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity data.
Kunze A; Huwyler J; Camenisch G; Poller B
Drug Metab Dispos; 2014 Sep; 42(9):1514-21. PubMed ID: 24989890
[TBL] [Abstract][Full Text] [Related]
16. Digoxin is not a substrate for organic anion-transporting polypeptide transporters OATP1A2, OATP1B1, OATP1B3, and OATP2B1 but is a substrate for a sodium-dependent transporter expressed in HEK293 cells.
Taub ME; Mease K; Sane RS; Watson CA; Chen L; Ellens H; Hirakawa B; Reyner EL; Jani M; Lee CA
Drug Metab Dispos; 2011 Nov; 39(11):2093-102. PubMed ID: 21849517
[TBL] [Abstract][Full Text] [Related]
17. Validation of cell-based OATP1B1 assays to assess drug transport and the potential for drug-drug interaction to support regulatory submissions.
Sharma P; Holmes VE; Elsby R; Lambert C; Surry D
Xenobiotica; 2010 Jan; 40(1):24-37. PubMed ID: 19919292
[TBL] [Abstract][Full Text] [Related]
18. Generation of Bayesian prediction models for OATP-mediated drug-drug interactions based on inhibition screen of OATP1B1, OATP1B1∗15 and OATP1B3.
van de Steeg E; Venhorst J; Jansen HT; Nooijen IH; DeGroot J; Wortelboer HM; Vlaming ML
Eur J Pharm Sci; 2015 Apr; 70():29-36. PubMed ID: 25603031
[TBL] [Abstract][Full Text] [Related]
19. Interactions of crizotinib and gefitinib with organic anion-transporting polypeptides (OATP)1B1, OATP1B3 and OATP2B1: gefitinib shows contradictory interaction with OATP1B3.
Sato T; Ito H; Hirata A; Abe T; Mano N; Yamaguchi H
Xenobiotica; 2018 Jan; 48(1):73-78. PubMed ID: 28005438
[TBL] [Abstract][Full Text] [Related]
20. Preclinical Mouse Models To Study Human OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions in Vivo.
Durmus S; Lozano-Mena G; van Esch A; Wagenaar E; van Tellingen O; Schinkel AH
Mol Pharm; 2015 Dec; 12(12):4259-69. PubMed ID: 26474710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
